YEAR
- 2013.12.12 Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Johnson BE, Mazor T, Hong C, Barnes M, Aihara K, McLean CY, Fouse SD, Yamamoto S, Ueda H, Tatsuno K, Asthana S, Jalbert LE, Nelson SJ, Bollen AW, Gustafson WC, Charron E, Weiss WA, Smirnov IV, Song JS, Olshen AB, Cha S, Zhao Y, Moore RA, Mungall AJ, Jones SJM, Hirst M, Marra MA, Saito N, Aburatani H, Mukasa A, Berger MS, Chang SM, Taylor BS, Costello JF.Science. 2014 Jan 10;343(6167):189-193. doi: 10.1126/science.1239947
- 2013.12.09 A mesodermal factor, T, specifies mouse germ cell fate by directly activating germline determinants. Aramaki S, Hayashi K, Kurimoto K, Ohta H, Yabuta Y, Iwanari H, Mochizuki Y, Hamakubo T, Kato Y, Shirahige K, Saitou M.Dev. Cell. 2013 Dec 09;27(5):516-29. doi: 10.1016/j.devcel.2013.11.001
- 2013.12.05 Aberrantly methylated genes in human papillary thyroid cancer and their association with BRAF/RAS mutation. Kikuchi Y, Tsuji E, Yagi K, Matsusaka K, Tsuji S, Kurebayashi J, Ogawa T, Aburatani H, Kaneda A.Front Genet. 2013;4:271. doi: 10.3389/fgene.2013.00271
- 2013.12.05 The HSP90 inhibitor 17-N-allylamino-17-demethoxy geldanamycin (17-AAG) synergizes with cisplatin and induces apoptosis in cisplatin-resistant esophageal squamous cell carcinoma cell lines via the Akt/XIAP pathway. Ui T, Morishima K, Saito S, Sakuma Y, Fujii H, Hosoya Y, Ishikawa S, Aburatani H, Fukayama M, Niki T, Yasuda Y.Oncol. Rep. 2014 Feb;31(2):619-24. doi: 10.3892/or.2013.2899
- 2013.12.04 The orally available Btk inhibitor ibrutinib (PCI-32765) protects against osteoclast-mediated bone loss. Shinohara M, Chang BY, Buggy JJ, Nagai Y, Kodama T, Asahara H, Takayanagi H.Bone. 2014 Mar;60:8-15. doi: 10.1016/j.bone.2013.11.025
- 2013.12.03 Conditional ablation of HMGB1 in mice reveals its protective function against endotoxemia and bacterial infection. Yanai H, Matsuda A, An J, Koshiba R, Nishio J, Negishi H, Ikushima H, Onoe T, Ohdan H, Yoshida N, Taniguchi T.Proc. Natl. Acad. Sci. U.S.A. 2013 Dec 17;110(51):20699-704. doi: 10.1073/pnas.1320808110
- 2013.11.26 H3F3A K27M mutations in thalamic gliomas from young adult patients. Aihara K, Mukasa A, Gotoh K, Saito K, Nagae G, Tsuji S, Tatsuno K, Yamamoto S, Takayanagi S, Narita Y, Shibui S, Aburatani H, Saito N.Neuro-oncology. 2014 Jan;16(1):140-6. doi: 10.1093/neuonc/not144
- 2013.11.18 Beneficial innate signaling interference for antibacterial responses by a Toll-like receptor-mediated enhancement of the MKP-IRF3 axis. Negishi H, Matsuki K, Endo N, Sarashina H, Miki S, Matsuda A, Fukazawa K, Taguchi-Atarashi N, Ikushima H, Yanai H, Nishio J, Honda K, Fujioka Y, Ohba Y, Noda T, Taniguchi S, Nishida E, Zhang Y, Chi H, Flavell RA, Taniguchi T.Proc. Natl. Acad. Sci. U.S.A. 2013 Dec 03;110(49):19884-9. doi: 10.1073/pnas.1320145110
CLOSE